Digestive Diseases and Sciences

, Volume 55, Issue 11, pp 3113–3119 | Cite as

The Cannabis Hyperemesis Syndrome Characterized by Persistent Nausea and Vomiting, Abdominal Pain, and Compulsive Bathing Associated with Chronic Marijuana Use: A Report of Eight Cases in the United States

  • Maria Soriano-Co
  • Mihaela Batke
  • Mitchell S. Cappell
Original Article

Abstract

Goals/Background

The cannabis hyperemesis syndrome, which is associated with chronic cannabis use, was recently reported in seven case reports and one clinical series of ten patients from Australia. We further characterize this syndrome with eight well-documented cases in the United States and report results of cannabis discontinuation and cannabis rechallenge.

Study Methods

Patients were identified by the three investigators in gastroenterology clinic or inpatient wards at William Beaumont Hospital from January to August 2009 based on chronic cannabis use; otherwise unexplained refractory, recurrent vomiting; and compulsive bathing. Charts were retrospectively analyzed with follow-up data obtained from subsequent physician visits and patient interviews.

Results

The eight patients on average were 32.4 ± 4.1 years old. Five were male. The mean interval between the onset of cannabis use and development of recurrent vomiting was 19.0 ± 3.7 years. Patients had a mean of 7.1 ± 4.3 emergency room visits, 5.0 ± 2.7 clinic visits, and 3.1 ± 1.9 admissions for this syndrome. All patients had visited at least one other hospital in addition to Beaumont Hospital. All patients had vomiting (mean vomiting episodes every 3.0 ± 1.7 h), compulsive bathing (mean = 5.0 ± 2.0 baths or showers/day; mean total bathing time = 5.0 ± 5.1 h/day), and abdominal pain. Seven patients took hot baths or showers, and seven patients experienced polydipsia. Four out of five patients who discontinued cannabis use recovered from the syndrome, while the other three patients who continued cannabis use, despite recommendations for cessation, continued to have this syndrome. Among those four who recovered, one patient had recurrence of vomiting and compulsive bathing with cannabis resumption.

Conclusions

Cannabis hyperemesis is characterized by otherwise unexplained recurrent nausea and vomiting, compulsive bathing, abdominal pain, and polydipsia associated with chronic cannabis use. This syndrome can occur in the United States as well as in Australia. Cannabis cessation may result in complete symptomatic recovery.

Keywords

Cannabis hyperemesis syndrome Marijuana use Nausea  Cyclic vomiting Functional GI disorders 

Abbreviations

CB

Cannabinoid receptor

CVS

Cyclic vomiting syndrome

BMI

Body mass index

HPA

Hypothalamic pituitary adrenal

THC

Tetrahydrocannabinol

References

  1. 1.
    Chang YH, Windish D. Cannabinoid hyperemesis relieved by compulsive bathing. Mayo Clin Proc. 2009;84(1):76–78.CrossRefPubMedGoogle Scholar
  2. 2.
    Chepyala P, Olden KW. Cyclic vomiting and compulsive bathing with chronic cannabis abuse. Clin Gastroenterol Hepatol. 2008;6(6):710–712.CrossRefPubMedGoogle Scholar
  3. 3.
    Donnino MW, Cocchi MN, Miller J, et al. Cannabinoid hyperemesis: a case series. J Emerg Med; 2009 Sep 16 [Epub ahead of print].Google Scholar
  4. 4.
    Roche E, Foster PN. Cannabinoid hyperemesis: not just a problem in Adelaide Hills. Gut. 2005;54(5):731.CrossRefPubMedGoogle Scholar
  5. 5.
    Singh E, Coyle W. Cannabinoid hyperemesis. Am J Gastroenterol. 2008;103(4):1048–1049.CrossRefPubMedGoogle Scholar
  6. 6.
    Sontineni SP, Chaudhary S, Sontineni V, et al. Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse. World J Gastroenterol. 2009;15(10):1264–1266.CrossRefPubMedGoogle Scholar
  7. 7.
    Allen JH, de Moore GM, Heddle R, et al. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis use. Gut. 2004;53(11):1566–1570.CrossRefPubMedGoogle Scholar
  8. 8.
    Compton W, Grant BF, Colliver J, et al. Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA. 2004;291(17):2114–2121.CrossRefPubMedGoogle Scholar
  9. 9.
    Stinson FS, Ruan WJ, Pickering R, Grant BF. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol Med. 2006;36(10):1447–1460.CrossRefPubMedGoogle Scholar
  10. 10.
    Howlett AC, Barth F, Bonnie TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptor. Pharmacol Rev. 2002;54(2):161–202.CrossRefPubMedGoogle Scholar
  11. 11.
    National Institutes of Health website: NIDA info facts: marijuana. National Institute on Drug Abuse. Available at: URL: http//www.nida.nih.gov/infofacts/marijuana. Accessed September 5, 2009.
  12. 12.
    Vaziri ND, Thomas R, Sterling M, et al. Toxicity with intravenous injection of crude marijuana extract. Clin Toxicol. 1981;18(3):353–366.CrossRefPubMedGoogle Scholar
  13. 13.
    Boekxstaens GE. Cannabinoid hyperemesis with the unusual symptom of compulsive bathing. Ned Tidjschr Geneeskd. 2005;149(26):1468–1471.Google Scholar
  14. 14.
    Cappell MS. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol. 2004;99(6):1175–1190.CrossRefPubMedGoogle Scholar
  15. 15.
    Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258(5090):1946–1949.CrossRefPubMedGoogle Scholar
  16. 16.
    Duncan M, Davison JS, Sharkey KA. Review article: endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther. 2005;22(8):667–683.CrossRefPubMedGoogle Scholar
  17. 17.
    Wallace D, Martin AL, Park B. Cannabinoid hyperemesis: marijuana puts patients in hot water. Aust Psychiatry. 2007;15(2):156–158.CrossRefGoogle Scholar
  18. 18.
    Ashton CH. Adverse effects of cannabis and cannabinoids. Br J Anaesth. 1999;83(4):637–649.PubMedGoogle Scholar
  19. 19.
    Cota D, Steiner M, Marsicano G, et al. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology. 2007;148(4):1574–1581.CrossRefPubMedGoogle Scholar
  20. 20.
    McCallum RW, Soykan I, Sridhar KR, et al. Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. Aliment Pharmacol Ther. 1999;13(1):77–80.CrossRefPubMedGoogle Scholar
  21. 21.
    Davis M, Maida V, Daeninck P, et al. The emerging role of cannabinoid neuromodulators in symptom management. Support Care Cancer. 2007;15(1):63–71.CrossRefPubMedGoogle Scholar
  22. 22.
    Degenhardt L, Hall WD. The adverse effects of cannabinoids: implications for use of medical marijuana. CMAJ. 2008;178(13):1685–1686.PubMedGoogle Scholar
  23. 23.
    Pertwee RG. Cannabinoids and the gastrointestinal tract. Gut. 2001;48(6):859–867.CrossRefPubMedGoogle Scholar
  24. 24.
    Pagotto U, Marsicano G, Fezza F, et al. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. J Clin Endocrinol Metab. 2001;86(6):2687–2696.CrossRefPubMedGoogle Scholar
  25. 25.
    Budney AJ, Roffman R, Stephens RS, et al. Marijuana dependence and its treatment. Addict Sci Clin Pract. 2007;4(1):16–18.CrossRefGoogle Scholar
  26. 26.
    Pagotto U, Marsicano G, Cota D, et al. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev. 2006;27(1):73–100.CrossRefPubMedGoogle Scholar
  27. 27.
    Abell TL, Adams KA, Boles RG, et al. Cyclic vomiting syndrome in adults. Neurogastroenterol Motil. 2008;20(4):269–284.CrossRefPubMedGoogle Scholar
  28. 28.
    Pareek N, Fleisher DR, Abell T. Cyclic vomiting syndrome: what a gastroenterologist needs to know. Am J Gastroenterol. 2007;102(12):2832–2840.CrossRefPubMedGoogle Scholar
  29. 29.
    Forbes D, Withers B, Silburn S, et al. Psychological and social characteristics and precipitants of vomiting in children with cyclical vomiting syndrome. Dig Dis Sci. 1999;44(8):19–22.Google Scholar
  30. 30.
    McRonald FE, Fleisher DR. Anticipatory anxiety in cyclical vomiting. BMC Pediatr. 2005;5(1):3.CrossRefPubMedGoogle Scholar
  31. 31.
    Stickler GB. Relationship between cyclic vomiting syndrome and migraine. Clin Pediatr. 2005;44(6):505–508.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Maria Soriano-Co
    • 1
  • Mihaela Batke
    • 2
  • Mitchell S. Cappell
    • 3
  1. 1.Department of MedicineWilliam Beaumont HospitalRoyal OakUSA
  2. 2.Division of GastroenterologyWilliam Beaumont HospitalRoyal OakUSA
  3. 3.Division of GastroenterologyWilliam Beaumont HospitalRoyal OakUSA

Personalised recommendations